Novartis Ceo Steers Drug Maker Back To R&d

Vasant Narasimhan, the 41-year-old chief executive at Novartis AG, is vowing data science and digital technologies will revolutionize the company’s drug-development pipeline.

Topics:  vasant narasimhan   novartis ag   drug   
BING NEWS:
  • NOVARTIS INDIA
    Abbott in the second largest drug maker in India but it competes with Novartis in several therapy areas like cardiovascular, and diabetes. However they also a tie up for certain drugs. Novartis ...
    10/25/2017 - 6:02 am | View Link
  • Novartis MS Drug Reduces Relapses
    The Swiss-based drug maker said it intends to seek regulatory approval for the drug, FTY720, in the U.S. and Europe by the end of 2009. If approved, FTY720 would offer patients with relapsing ...
    12/11/2008 - 11:16 pm | View Link
  • More

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News